Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
333.99
-1.54 (-0.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
39
40
Next >
Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today
June 05, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
Amgen Unusual Options Activity For June 01
June 01, 2023
Via
Benzinga
Why AbbVie and Amgen Are Moving Lower Today
June 01, 2023
An ultra-low-priced biosimilar may negatively impact both biotechs.
Via
The Motley Fool
Is Amgen a Good Dividend Stock?
June 01, 2023
The biotech's yield is near an all-time high right now.
Via
The Motley Fool
Check Out What Whales Are Doing With AMGN
May 23, 2023
Via
Benzinga
Amgen's Debt Overview
May 22, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
May 19, 2023
Via
Benzinga
Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income
May 29, 2023
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio.
Via
Talk Markets
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
May 26, 2023
Biotech-giant Amgen aims to launch a rival.
Via
The Motley Fool
3 Dogs of the Dow for High-Yield Investors
May 25, 2023
These Dogs of the Dow boast high dividend yields and will hold up well in a potential recession. Let's take a look.
Via
InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
May 24, 2023
Should Pfizer and Seagen investors be worried?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 23, 2023
Via
Benzinga
3 Safe Dividend Stocks to Beat Inflation
May 19, 2023
Look for businesses that thrive in any economic environment.
Via
The Motley Fool
Why Horizon Therapeutics Stock Is Crashing Today
May 16, 2023
The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen.
Via
The Motley Fool
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
May 23, 2023
Pfizer stock surged on its diabetes news this week, but one analyst says there's a key piece missing from the story.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
May 22, 2023
Pfizer's diabetes drug led to faster weight loss than Novo Nordisk's Ozempic.
Via
Investor's Business Daily
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
May 19, 2023
Chips, software and AI plays were strong. But leadership remains narrow.
Via
Investor's Business Daily
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
May 18, 2023
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
Via
Talk Markets
TScan Therapeutics Shares Fall After Preliminary Data Highlight In Leukemia Patients
May 17, 2023
TScan Therapeutics Inc (NASDAQ: TCRX) announced a poster presentation highlighting preliminary data from the Phase 1 umbrella clinical trial evaluating TSC-100 and TSC-101 targeting minor...
Via
Benzinga
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
May 17, 2023
Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
May 17, 2023
Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.
Via
The Motley Fool
Is This Dow Jones Stock a Buy for Income Investors?
May 17, 2023
This pharmaceutical company is dedicated to maintaining its track record of innovation.
Via
The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.
Via
The Motley Fool
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
May 16, 2023
In a rare move to block a large pharma deal, the U.S.
Via
Benzinga
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
May 16, 2023
Their declines weighed on the broader market.
Via
The Motley Fool
Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories
May 16, 2023
Benzinga Former SVB Chief Blames Fed, Media Hype For Bank's Devastating Collapse
Via
Benzinga
HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today
May 16, 2023
Horizon Therapeutics (HZNP) stock is sinking after the FTC reportedly decided to sue to block its merger with Amgen (AMGN).
Via
InvestorPlace
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.